scispace - formally typeset
M

Matilde Todaro

Researcher at University of Palermo

Publications -  163
Citations -  19136

Matilde Todaro is an academic researcher from University of Palermo. The author has contributed to research in topics: Cancer stem cell & Stem cell. The author has an hindex of 55, co-authored 154 publications receiving 17289 citations. Previous affiliations of Matilde Todaro include University of Rome Tor Vergata.

Papers
More filters
Journal ArticleDOI

Role of apoptosis in autoimmunity.

TL;DR: Basic research has indicated apoptosis as the pivotal molecular mechanism leading to autoimmunity and recently cytokines have been invoked in the regulation of the apoptosis-related factors and death receptors in autoimmune target destruction.
Journal ArticleDOI

Prevention of Chemotherapy-Induced Anemia and Thrombocytopenia by Constant Administration of Stem Cell Factor

TL;DR: Stem cell factor treatment can prevent the occurrence of chemotherapy-induced anemia and thrombocytopenia in mice, indicating a potential use of this cytokine in the supportive therapy of cancer patients.
Journal ArticleDOI

MiR-205-5p inhibition by locked nucleic acids impairs metastatic potential of breast cancer cells.

TL;DR: It is shown that miR-205-5p regulates tumorigenic properties of breast cancer cells, as well as epithelial to mesenchymal transition, and can be obtained with the use of specific locked nucleic acids oligonucleotides in vivo suggesting a future potential use of this approach in therapy.
Journal ArticleDOI

Colorectal cancer defeating? Challenge accepted!

TL;DR: Increasing understanding of the cellular and molecular mechanisms that regulate CSC quiescence and cell cycle regulation, self-renewal, chemotaxis and resistance to cytotoxic agents, is expected to eventually result in tailor-made therapies with a significant impact on the morbidity and overall survival of colorectal cancer patients.
Journal ArticleDOI

Normal vs cancer thyroid stem cells: the road to transformation

TL;DR: New insights into thyroid SCs are critically discussed as a potential source of cancer formation in light of the available information on the oncogenic role of genetic modifications that occur during thyroid cancer development.